Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins

Evan A Elko, Georgia A Nelson, Heather L Mead, Erin J Kelley, Virginia Le Verche, Angelo A Cardoso, Jennifer L Ely, Annalee S Boyle, Alejandra Piña, Sierra N Henson, Fatima Rahee, Paul S Keim, Kimberly R Celona, Jinhee Yi, Erik W Settles, George C Yu, Sheldon R Morris, John A Zaia, Jason T Ladner, John A Altin
doi: https://doi.org/10.1101/2022.01.24.22269542
Evan A Elko
1The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgia A Nelson
2The Translational Genomics Research Institute (TGen), Phoenix and Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather L Mead
2The Translational Genomics Research Institute (TGen), Phoenix and Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin J Kelley
2The Translational Genomics Research Institute (TGen), Phoenix and Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginia Le Verche
3Center for Gene Therapy, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelo A Cardoso
3Center for Gene Therapy, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer L Ely
2The Translational Genomics Research Institute (TGen), Phoenix and Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annalee S Boyle
2The Translational Genomics Research Institute (TGen), Phoenix and Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandra Piña
1The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sierra N Henson
2The Translational Genomics Research Institute (TGen), Phoenix and Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fatima Rahee
2The Translational Genomics Research Institute (TGen), Phoenix and Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul S Keim
1The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimberly R Celona
1The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinhee Yi
1The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik W Settles
1The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George C Yu
4George C Yu, MD, Inc., Camarillo, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheldon R Morris
5University of California San Diego CIRM Alpha Stem Cell Clinic, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John A Zaia
3Center for Gene Therapy, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason T Ladner
1The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John A Altin
2The Translational Genomics Research Institute (TGen), Phoenix and Flagstaff, AZ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jaltin@tgen.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The COVID-19 pandemic has triggered the first widespread vaccination campaign against a coronavirus. Most vaccinated subjects are naïve to SARS-CoV-2, however almost all have previously encountered other coronaviruses (CoVs) and the role of this immunity in shaping the vaccine response remains uncharacterized. Here we use longitudinal samples and highly-multiplexed serology to identify mRNA-1273 vaccine-induced antibody responses against a range of CoV Spike epitopes and in both phylogenetically conserved and non-conserved regions. Whereas reactivity to SARS-CoV-2 epitopes showed a delayed but progressive increase following vaccination, we observed distinct kinetics for the endemic CoV homologs at two conserved sites in Spike S2: these became detectable sooner, and decayed at later timepoints. Using homolog-specific depletion and alanine-substitution experiments, we show that these distinctly-evolving specificities result from cross-reactive antibodies as they mature against rare, polymorphic residues within these epitopes. Our results reveal mechanisms for the formation of antibodies with broad reactivity against CoVs.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the NIAID (U24AI152172, U24AI152172-01S1, U24AI152172-IOF, PI: J.A.A.), the California Institute for Regenerative Medicine (CLIN2COVID19-11775, PI: J.A.Z), the State of Arizona Technology and Research Initiative Fund (TRIF, administered by the Arizona Board of Regents, through Northern Arizona University), the Flinn Foundation, and The Cowden Endowment for Microbiology.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The IRB of The Translational Genomics Research Institute (TGen) gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 25, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins
Evan A Elko, Georgia A Nelson, Heather L Mead, Erin J Kelley, Virginia Le Verche, Angelo A Cardoso, Jennifer L Ely, Annalee S Boyle, Alejandra Piña, Sierra N Henson, Fatima Rahee, Paul S Keim, Kimberly R Celona, Jinhee Yi, Erik W Settles, George C Yu, Sheldon R Morris, John A Zaia, Jason T Ladner, John A Altin
medRxiv 2022.01.24.22269542; doi: https://doi.org/10.1101/2022.01.24.22269542
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 vaccination recruits and matures cross-reactive antibodies to conserved epitopes in endemic coronavirus Spike proteins
Evan A Elko, Georgia A Nelson, Heather L Mead, Erin J Kelley, Virginia Le Verche, Angelo A Cardoso, Jennifer L Ely, Annalee S Boyle, Alejandra Piña, Sierra N Henson, Fatima Rahee, Paul S Keim, Kimberly R Celona, Jinhee Yi, Erik W Settles, George C Yu, Sheldon R Morris, John A Zaia, Jason T Ladner, John A Altin
medRxiv 2022.01.24.22269542; doi: https://doi.org/10.1101/2022.01.24.22269542

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (419)
  • Anesthesia (97)
  • Cardiovascular Medicine (895)
  • Dentistry and Oral Medicine (167)
  • Dermatology (101)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (404)
  • Epidemiology (8757)
  • Forensic Medicine (4)
  • Gastroenterology (403)
  • Genetic and Genomic Medicine (1856)
  • Geriatric Medicine (176)
  • Health Economics (386)
  • Health Informatics (1283)
  • Health Policy (642)
  • Health Systems and Quality Improvement (490)
  • Hematology (206)
  • HIV/AIDS (389)
  • Infectious Diseases (except HIV/AIDS) (10535)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (217)
  • Neurology (1747)
  • Nursing (100)
  • Nutrition (265)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (458)
  • Oncology (961)
  • Ophthalmology (279)
  • Orthopedics (107)
  • Otolaryngology (174)
  • Pain Medicine (117)
  • Palliative Medicine (41)
  • Pathology (263)
  • Pediatrics (556)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (218)
  • Psychiatry and Clinical Psychology (1840)
  • Public and Global Health (3971)
  • Radiology and Imaging (650)
  • Rehabilitation Medicine and Physical Therapy (341)
  • Respiratory Medicine (532)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (165)
  • Surgery (196)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (79)